PGF and diabetic macular edema: The latter may be due to the effect that PlGF has upon tight junctions in the retina [37], and a PlGF-targeting therapeutic has since been developed for diabetic macular edema (DME) [35], a complication of DR linked with vascular permeability that is also the main cause of DR-associated blindness [12].